Recon: China approves Pfizer’s COVID drug Paxlovid; Biogen, others respond to CMS’ coverage proposal for Alzheimer’s drugs

Recon

ReconJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy